Cellular toxicity induced by the 26-kDa fragment and amyotrophic lateral sclerosis-associated mutant forms of TAR DNA-binding protein 43 in human embryonic stem cell-derived motor neurons

Neurology and Clinical Neuroscience

Volumn 1, Issue 1, 2013, Pages 24-31

  Nishimoto, Yoshinori ^a   Okano, Hirotaka J ^a,b   Imai, Takao ^a   Poole, Aleksandra J ^c   Suzuki, Norihiro ^a   Keirstead, Hans S ^c   Okano, Hideyuki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenosine deaminase acting on RNA 2; Amyotrophic lateral sclerosis; Human embryonic stem cell; Magnetofection; Motor neuron; TAR DNA binding protein 43

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE DEAMINASE ACTING ON RNA 2; BETA TUBULIN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEIN; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; EMBRYONIC STEM CELL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MAGNETOFECTION; MOTONEURON; MUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84881165165     PISSN: None     EISSN: 20494173     Source Type: Journal    
DOI: 10.1002/ncn3.2     Document Type: Article

References (27)

1. Gitcho MA, Baloh RH, Chakraverty S et al. TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol. 2008; 63: 535-8.
2. Kabashi E, Valdmanis PN, Dion P et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008; 40: 572-4.
3. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009; 323: 1205-8.
4. Vance C, Rogelj B, Hortobagyi T et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009; 323: 1208-11.
5. Maruyama H, Morino H, Ito H et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010; 465: 223-6.
6. DeJesus-Hernandez M, Mackenzie IR, Boeve BF et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011; 72: 245-56.
7. Renton AE, Majounie E, Waite A et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72: 257-68.
8. Kawahara Y, Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl Acad. Sci. USA 2012; 109: 3347-52.
9. Ayala YM, De Conti L, Avendano-Vazquez SE et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 2010; 30: 277-88.
10. Nishimoto Y, Ito D, Yagi T et al. Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43. J. Biol. Chem. 2010; 285: 608-19.
11. Arai T, Hasegawa M, Nonoka T et al. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology 2010; 30: 170-81.
12. Neumann M, Sampathu DM, Kwong LK et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-3.
13. Wyatt TJ, Rossi SL, Siegenthaler MM. Human motor neuron progenitor transplantation leads to endogenous neuronal sparing in 3 models of motor neuron loss. Stem Cells Int. 2011; 2011: 207230.
14. Kawahara Y, Ito K, Sun H et al. Glutamate receptors: RNA editing and death of motor neurons. Nature 2004; 427: 801.
15. Yamashita T, Hideyama T, Teramoto S, Kwak S. The abnormal processing of TDP-43 is not an upstream event of reduced ADAR2 activity in ALS motor neurons. Neurosci. Res. 2012; 73: 153-60.
16. Naka H, Nakamura S, Shimazaki T, Okano H. Requirement for COUP-TFI and II in the temporal specification of neural stem cells in CNS development. Nat. Neurosci. 2008; 11: 1014-23.
17. Miyoshi H, Blomer U, Takahashi M et al. Development of a self-inactivating lentivirus vector. J. Virol. 1998; 72: 8150-7.
18. Fallini C, Bassell GJ, Rossoll W. High-efficiency transfection of cultured primary motor neurons to study protein localization, trafficking, and function. Mol. Neurodegener. 2010; 5: 17.
19. Nishimoto Y, Yamashita T, Hideyama T et al. Determination of editors at the novel A-to-I editing positions. Neurosci. Res. 2008; 61: 201-206.
20. Rossi SL, Nistor G, Wyatt T et al. Histological and functional benefit following transplantation of motor neuron progenitors to the injured rat spinal cord. PLoS ONE 2010; 5: e11852.
21. Buerli T, Pellegrino C, Baer K et al. Efficient transfection of DNA or shRNA vectors into neurons using magnetofection. Nat. Protoc. 2007; 2: 3090-101.
22. Tan Z, Sun X, Hou FS et al. Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration. Cell Death Differ. 2007; 14: 1721-32.
23. Egawa N, Kitaoka S, Tsukita K et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl. Med. 2012; 4: 145ra104.
24. Hideyama T, Teramoto S, Hachiga K et al. Co-occurrence of TDP-43 mislocalization with reduced activity of an RNA editing enzyme, ADAR2, in aged mouse motor neurons. PLoS ONE 2012; 7: e43469.
25. Bilican B, Serio A, Barmada SJ et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc. Natl Acad. Sci. USA 2012; 109: 5803-8.
26. Gurney ME, Pu H, Chiu AY et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994; 264: 1772-5.
27. Hideyama T, Yamashita T, Suzuki T et al. Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2. J. Neurosci. 2010; 30: 11917-25.